Basak Mansiz-Kaplan

Dr. Basak Mansiz-Kaplan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in American Journal of Physical Medicine & Rehabilitation
Verified
Journal Article
Closed access
BMBasak Mansiz-Kaplan
Basak Mansiz-Kaplan
BNBaris Nacir
Baris Nacir
SPSecil Pervane-Vural
Secil Pervane-Vural
BDBurcu Duyur-Cakit
Burcu Duyur-Cakit
HGHakan Genc
Hakan Genc
Objective: The aim of the study was to evaluate the efficacy of dextrose prolotherapy in the treatment of chronic resistant plantar fasciitis through comparison with a control group. Design: In this double-blind, randomized, controlled study, the patients were divided into two groups. The prolotherapy group (n = 30) was administered 5 ml of 30% dextrose, 4 ml of saline, and 1 ml of 2% lidocaine mixture (15% dextrose solution) and the control group was given 9 ml of saline and 1 ml of 2% lidocaine mixture twice at a 3-wk interval. During the 15-wk follow-up period, pain intensity was measured using the visual analog scale during activity and at rest. The foot function index was used to measure pain and disability. The plantar fascia thickness was measured by ultrasonography. The measurements were undertaken before treatment and at posttreatment weeks 7 and 15. Results: Improvements in visual analog scale during activity, at rest, foot function index (all subgroups), and plantar fascia thickness measured at the 7th and 15th weeks were significantly higher in the prolotherapy group compared with the control group (P < 0.001). Conclusions: Dextrose prolotherapy has efficacy up to 15 wks and can be used as an alternative method in the treatment of chronic resistant plantar fasciitis.

1 July 2019 in Journal of Hand Therapy
Verified
Journal Article
Closed access
BMBasak Mansiz-Kaplan
Basak Mansiz-Kaplan
GAGulseren Akyuz
Gulseren Akyuz
SKSerdar Kokar
Serdar Kokar
IYIlker Yagci
Ilker Yagci

9 June 2022 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
BMBasak Mansiz-Kaplan
Basak Mansiz-Kaplan
BNBaris Nacir
Baris Nacir
SPSecil Pervane-Vural
Secil Pervane-Vural
OTOlcay Tosun-Meric
Olcay Tosun-Meric
BDBurcu Duyur-Cakit
Burcu Duyur-Cakit
HGHakan Genc
Hakan Genc

31 March 2020 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
BMBasak Mansiz-Kaplan
Basak Mansiz-Kaplan
FAF. Figen Ayhan
F. Figen Ayhan
MCMihriban Cagli
Mihriban Cagli
FAFatih Atik
Fatih Atik
IEİbRahim Ece
İbRahim Ece
Background: Only a small percentage of pediatric chest pain is of cardiac origin and the most common detected cause is musculoskeletal. Among musculoskeletal causes, acute chest pain is better described, with the causes of chronic pain not being adequately investigated in the literature. The aim of studuy is to evaluate the musculoskeletal causes of non-cardiac chest pain and investigate the relationship of chest pain with child abuse and central sensitization. Methods: Patients aged 12 to 18 years presenting with chest pain for at least 3 months were evaluated by a pediatric cardiologist and those without an organic pathology were referred to the physical medicine and rehabilitation clinic. In addition to detailed history and physical examination, juvenile fibromyalgia was questioned according to the 2016 revised diagnostic criteria of the American College of Rheumatology. The visual analog scale (to measure intensity of chest pain), the Central Sensitization Inventory (to evaluate the presence of central sensitization), the Hospital Anxiety Depression Scale (to determine depression and anxiety), the Childhood Trauma Questionnaire (to assess the presence of child abuse) were administered. Results: The study was completed with 64 patients. Twenty-six percent of patient (n = 17) were diagnosed with juvenile fibromyalgia, and central sensitization was detected in 34.4% (n = 22). Pain intensity, anxiety, depression and abuse scores were higher in patients with juvenile fibromyalgia than those without juvenile fibromyalgia and in patients with central sensitization compared to those without central sensitization (p < 0.001 for both). Higher scores of pain were related with child abuse [beta = 0.763, p < 0.001, (%95 CI, 4.397; 8.841)] and central sensitization of pain [beta = 0.382, p = 0.008 (95% CI: (0.986;6.231)] in regression analyses. Conclusion: In this study, juvenile fibromyalgia was detected as a cause of non-cardiac chest pain. Juvenile fibromyalgia or central sensitization may also indicate childhood abuse.

15 January 2024 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
FAFikriye Figen Ayhan
Fikriye Figen Ayhan
AÇAyşegül Demirci Çoban
Ayşegül Demirci Çoban
AKAyça Utkan Karasu
Ayça Utkan Karasu
BKBelgin Karaoğlan
Belgin Karaoğlan
EÇEce Çınar
Ece Çınar
MDMeltem Dalyan
Meltem Dalyan
Objectives: This study aimed to evaluate the effects of the combined hydrolyzed type 2 collagen, methylsulfonylmethane (MSM), glucosamine sulfate (GS), and chondroitin sulfate (CS) supplement on knee pain intensity in patients with knee osteoarthritis (OA). Patients and methods: This multicenter, observational, noninterventional study included 98 patients (78 females, 20 males; mean age: 52.8±6.5 years; range, 40 to 64 years) who had Grade 1-3 knee OA between May 2022 and November 2022. The patients were prescribed the combination of hydrolyzed type 2 collagen, MSM, GS, and CS as a supplement for knee OA. The sachet form of the combined supplement containing 1250 mg hydrolyzed type 2 collagen, 750 mg MSM, 750 mg GS, and 400 mg CS was used once daily for two consecutive months. Patients were evaluated according to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Visual Analog Scale (VAS)-pain, and Health Assessment Questionnaire (HAQ). Patients were scheduled to visit for follow-up four weeks (Visit 2) and eight weeks (Visit 3) after Visit 1 (baseline; day 0 of the study). Results: For the VAS-pain, WOMAC, WOMAC-subscale, and HAQ scores, the differences in improvement between the three visits were significant (p<0.001 for all). The patient compliance with the supplement was a median of 96.77%, both for Visit 2 and Visit 3. Conclusion: The combination of hydrolyzed type 2 collagen, MSM, GS, and CS for eight weeks in knee OA was considered an effective and safe nutritional supplement.

1 February 2018 in Journal of Electromyography and Kinesiology
Verified
Journal Article
Closed access
BMBasak Mansiz-Kaplan
Basak Mansiz-Kaplan
MAMerve Akdeniz-Leblecicier
Merve Akdeniz-Leblecicier
IYIlker Yagci
Ilker Yagci